Invesaro

Stocks Comparison

Balchem vs Chemours: revenue, profit, margins and growth compared

Balchem brought in $1B of revenue in fiscal 2025, Chemours $5.8B in fiscal 2025. Revenue changed by +8.8% at Balchem and +0.4% at Chemours on the year before, so Balchem grew faster. Balchem kept 14.9% of its revenue as net profit, Chemours -6.6%.

Side by side, latest fiscal year

BCPCCC
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1B$5.8B
Revenue growth+8.8%+0.4%
Net income$154.8M-$386M
Net margin14.9%-6.6%
Free cash flown/a$51M
Free cash flow marginn/a0.9%
Earnings per share (diluted)$4.75-$2.57
Cash$74.6M$670M
Debtn/a$4.1B
Price to earnings35.4n/a
Market value$5.4B$2.2B
Dividend yield0.57%3.54%
Rank by revenue in sector#269 of 451 · Industrials#109 of 451 · Industrials

Over the years

Revenue
BCPC FY2018: $643.7MBCPC FY2019: $643.7MBCPC FY2020: $703.6MBCPC FY2021: $799MBCPC FY2022: $942.4MBCPC FY2023: $922.4MBCPC FY2024: $953.7MBCPC FY2025: $1BCC FY2018: $6.6BCC FY2019: $5.5BCC FY2020: $5BCC FY2021: $6.3BCC FY2022: $6.8BCC FY2023: $6.1BCC FY2024: $5.8BCC FY2025: $5.8BFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $1BCC $5.8B
Net income
BCPC FY2018: $78.6MBCPC FY2019: $79.7MBCPC FY2020: $84.6MBCPC FY2021: $96.1MBCPC FY2022: $105.4MBCPC FY2023: $108.5MBCPC FY2024: $128.5MBCPC FY2025: $154.8MCC FY2018: $995MCC FY2019: -$52MCC FY2020: $219MCC FY2021: $608MCC FY2022: $578MCC FY2023: -$253MCC FY2024: $69MCC FY2025: -$386MFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $154.8MCC -$386M
Net margin
BCPC FY2018: 12.2%BCPC FY2019: 12.4%BCPC FY2020: 12.0%BCPC FY2021: 12.0%BCPC FY2022: 11.2%BCPC FY2023: 11.8%BCPC FY2024: 13.5%BCPC FY2025: 14.9%CC FY2018: 15.0%CC FY2019: -0.9%CC FY2020: 4.4%CC FY2021: 9.6%CC FY2022: 8.5%CC FY2023: -4.2%CC FY2024: 1.2%CC FY2025: -6.6%FY18FY19FY20FY21FY22FY23FY24FY25
BCPC 14.9%CC -6.6%
Revenue growth
BCPC FY2019: +0.0%BCPC FY2020: +9.3%BCPC FY2021: +13.6%BCPC FY2022: +17.9%BCPC FY2023: -2.1%BCPC FY2024: +3.4%BCPC FY2025: +8.8%CC FY2019: -16.8%CC FY2020: -10.1%CC FY2021: +27.7%CC FY2022: +7.7%CC FY2023: -11.0%CC FY2024: -4.9%CC FY2025: +0.4%FY19FY20FY21FY22FY23FY24FY25
BCPC +8.8%CC +0.4%
Free cash flow
BCPC FY2018: $99.5MBCPC FY2019: $98.7MBCPC FY2020: $118.4MBCPC FY2021: $124.4MBCPC FY2022: $89.5MCC FY2018: $642MCC FY2019: $169MCC FY2020: $540MCC FY2021: $537MCC FY2022: $448MCC FY2023: $186MCC FY2024: -$993MCC FY2025: $51MFY18FY19FY20FY21FY22FY23FY24FY25
BCPC $89.5MCC $51M

Fiscal years as each company reports them; the two may end in different months.

Questions about Balchem and Chemours

Which is bigger by revenue, Balchem or Chemours?

Chemours is bigger by revenue: $5.8B in fiscal 2025, against $1B for Balchem in fiscal 2025.

Which keeps more of its revenue as profit, Balchem or Chemours?

Balchem had a net margin of 14.9% in fiscal 2025; Chemours had -6.6% in fiscal 2025.

Which grew revenue faster, Balchem or Chemours?

In their latest fiscal years revenue changed by +8.8% at Balchem and +0.4% at Chemours.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies